Eli Lilly is buying Centessa Pharmaceuticals in a deal worth at least $6.3 billion, picking up a promising narcolepsy ...
The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of ...
They never gave us false hope, but they promised to try everything”: an excerpt from “The Elusive Body” by Alexandra ...
Sellers of health savings accounts see an opening for expanding their market, and they’re ramping up lobbying efforts to ...
U.S. venture capital firms are no longer waiting for Chinese biotech assets to surface before investing in them — they’re ...
Takeda Pharmaceuticals, the largest biopharma in Mass., will lay off 250 workers in Cambridge beginning in July.
How over-the-top social media videos about psychedelics could undermine the field’s efforts to get its drugs approved.
Jimini Health has raised $17 million in seed funding as it seeks to launch its mental health AI platform Sage with large ...
Gallo is founding director of the USF Institute for Translational Virology & Innovation and co-founder and international ...
Shebani Sethi is at the vanguard of metabolic psychiatry, a field that investigates the link between diet and serious mental ...
A JAMA study details how lead lingers in the body and how it can elevate blood pressure, harm blood vessel lining, and raise risk of heart attack.
Insilico Medicine signed a large deal with Eli Lilly over AI-driven drug discovery, and there’s a psoriasis race underway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results